• Contact us
  • Customer support
  • Login
  • Home
  • Technology
    • Introduction to Ex Vivo Lung Perfusion
    • The Ex Vivo Lung Perfusion Process
    • Clinical
    • Protocols
    • Starting your clinical EVLP program
    • Articles about EVLP
    • EVLP with Manual method
    • EVLP with XPS™
    • Training and workshops
    • Patents
  • Products
    • Our Products
    • XPS™
    • XPS Disposable Lung Kit™
    • STEEN Solution™
    • PERFADEX® Plus
    • XVIVO
      Organ Chamber™
    • XVIVO
      Lung Cannula Set™
    • Instruction for Use
  • Knowledge
    • NOVEL Lung Trial
    • Literature
    • Insights
  • Media
    • Videos
    • Webinars
    • Establishing a successful EVLP program
  • About us
    • About XVIVO
    • History
    • Our market
    • News
    • Career
    • Working at XVIVO
  • Corporate
    • Corporate
    • The share
      • Info
      • Ownership structure
      • Insiders (PDMRs)
    • Press releases
      • 2023
      • 2022
      • 2021
      • 2020
      • 2019
      • 2018
      • 2017
      • 2016
      • 2015
      • 2014
      • 2013
      • 2012
    • Financial calendar
    • Financial reports
    • Financial reports – ESEF
    • Prospectus and material offerings
      • Material offerings
      • Prospectus
    • Financial presentations
      • Capital Markets Day
      • Earnings calls
    • Corporate governance
      • Article of Association
      • General meetings
      • Board of Directors
      • Senior Management
      • Auditors
      • Board Committees
      • Board and Senior Management share holdings
      • Guidelines for remuneration
      • Nomination Committee
      • Corporate Governance Reports
    • Analyst Coverage
    • Code of Conduct
    • Environmental Policy
    • Code of Conduct for Suppliers
    • Privacy policy
    • Contact us
    • Subscribe
    • Thank you
    • Error
XVIVO
  • Contact us
  • Customer support
  • Home
  • Technology
    • Introduction to Ex Vivo Lung Perfusion
    • The Ex Vivo Lung Perfusion Process
    • Clinical
    • Protocols
    • Starting your clinical EVLP program
    • Articles about EVLP
    • EVLP with Manual method
    • EVLP with XPS™
    • Training and workshops
    • Patents
  • Products
    • Our Products
    • XPS™
    • XPS Disposable Lung Kit™
    • STEEN Solution™
    • PERFADEX® Plus
    • XVIVO
      Organ Chamber™
    • XVIVO
      Lung Cannula Set™
    • Instruction for Use
  • Knowledge
    • NOVEL Lung Trial
    • Literature
    • Insights
  • Media
    • Videos
    • Webinars
    • Establishing a successful EVLP program
  • About us
    • About XVIVO
    • History
    • Our market
    • News
    • Career
    • Working at XVIVO
  • Corporate
    • Corporate
    • The share
      • Info
      • Ownership structure
      • Insiders (PDMRs)
    • Press releases
      • 2023
      • 2022
      • 2021
      • 2020
      • 2019
      • 2018
      • 2017
      • 2016
      • 2015
      • 2014
      • 2013
      • 2012
    • Financial calendar
    • Financial reports
    • Financial reports – ESEF
    • Prospectus and material offerings
      • Material offerings
      • Prospectus
    • Financial presentations
      • Capital Markets Day
      • Earnings calls
    • Corporate governance
      • Article of Association
      • General meetings
      • Board of Directors
      • Senior Management
      • Auditors
      • Board Committees
      • Board and Senior Management share holdings
      • Guidelines for remuneration
      • Nomination Committee
      • Corporate Governance Reports
    • Analyst Coverage
    • Code of Conduct
    • Environmental Policy
    • Code of Conduct for Suppliers
    • Privacy policy
    • Contact us
    • Subscribe
    • Thank you
    • Error
  • Corporate
  • The share
    • Info
    • Ownership structure
    • Insiders (PDMRs)
  • Press releases
    • 2023
    • 2022
    • 2021
    • 2020
    • 2019
    • 2018
    • 2017
    • 2016
    • 2015
    • 2014
    • 2013
    • 2012
  • Financial calendar
  • Financial reports
  • Financial reports – ESEF
  • Prospectus and material offerings
    • Material offerings
    • Prospectus
  • Financial presentations
    • Capital Markets Day
    • Earnings calls
  • Corporate governance
    • Article of Association
    • General meetings
    • Board of Directors
    • Senior Management
    • Auditors
    • Board Committees
    • Board and Senior Management share holdings
    • Guidelines for remuneration
    • Nomination Committee
    • Corporate Governance Reports
  • Analyst Coverage
  • Code of Conduct
  • Environmental Policy
  • Code of Conduct for Suppliers
  • Privacy policy
  • Contact us
  • Subscribe
  • Thank you
  • Error

Press releases 2018

  • All press releases
  • Regulatory Press Releases
2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012
2018-12-07 13:30
News
IR
English
Corporate Information
Other Corporate Information
Professor Stig Steen’s heart preservation technology required for successful transplantation from pigs to baboons
2018-12-07 13:30
News
IR
Swedish
Corporate Information
Other Corporate Information
Professor Stig Steens hjärtpreservationsteknologi en förutsättning för lyckade hjärttransplantationer från gris till babian
2018-10-26 07:30
News
IR
Swedish
Regulatory
MAR
Report
Interim
Q3
XVIVO Perfusion AB (publ) delårsrapport januari – september 2018
2018-10-26 07:30
News
IR
English
Regulatory
MAR
Report
Interim
Q3
XVIVO Perfusion AB (publ) Interim Report January – September 2018
2018-10-17 15:00
News
IR
Swedish
Corporate Information
Other Corporate Information
Telefonkonferens avseende delårsrapport
2018-10-17 15:00
News
IR
English
Corporate Information
Other Corporate Information
Conference call on Interim Report
2018-09-24 15:30
News
IR
English
Corporate Information
Nomination Committee
Nomination Committee of XVIVO Perfusion AB (publ)
2018-09-24 15:30
News
IR
Swedish
Corporate Information
Nomination Committee
Valberedning i XVIVO Perfusion AB (publ)
2018-07-20 08:00
News
IR
English
Regulatory
MAR
VPML
Report
Interim
Q2
Interim report January-June 2018
2018-07-20 08:00
News
IR
Swedish
Regulatory
MAR
VPML
Report
Interim
Q2
Delårsrapport januari-juni 2018
2018-07-12 10:00
News
IR
Swedish
Corporate Information
Other Corporate Information
Telefonkonferens avseende delårsrapport
2018-07-12 10:00
News
IR
English
Corporate Information
Other Corporate Information
Conference call on Interim Report
2018-06-29 08:30
News
IR
English
Regulatory
LHFI
Corporate Action
Shares
Change in number of shares and votes in XVIVO Perfusion
2018-06-29 08:30
News
IR
Swedish
Regulatory
LHFI
Corporate Action
Shares
Förändring av antalet aktier och röster i XVIVO Perfusion
2018-06-25 10:00
News
IR
Swedish
Corporate Information
Other Corporate Information
Perfadex Plus godkänt av FDA
2018-06-25 10:00
News
IR
English
Corporate Information
Other Corporate Information
Perfadex Plus approved by the FDA
2018-06-14 20:00
News
IR
English
Regulatory
Listing Regulation
Corporate Information
Other Corporate Information
XVIVO Perfusion changes the date of reporting of the interim report January - June 2018 to July 20, 2018
2018-06-14 20:00
News
IR
Swedish
Regulatory
Listing Regulation
Corporate Information
Other Corporate Information
XVIVO Perfusion ändrar datum för rapportering av delårsrapport januari – juni 2018 till den 20 juli 2018
2018-06-12 07:30
News
IR
Swedish
Regulatory
MAR
Corporate Information
Other Corporate Information
UNITED THERAPEUTICS OCH XVIVO PERFUSION INLEDER SAMARBETE FÖR ATT MINSKA ORGANBRISTEN GENOM UTÖKAD TJÄNST INOM ORGANUTVÄRDERING
2018-06-12 07:30
News
IR
English
Regulatory
MAR
Corporate Information
Other Corporate Information
UNITED THERAPEUTICS AND XVIVO PERFUSION ANNOUNCE COLLABORATION TO REDUCE ORGAN SHORTAGE THROUGH EXPANSION OF ORGAN EVALUATION SERVICE
2018-06-05 08:30
News
IR
Swedish
Regulatory
MAR
Corporate Information
Other Corporate Information
Xvivo Perfusion lanserar Perfadex Plus, en uppgraderad ready to use version av Perfadex
2018-06-05 08:30
News
IR
English
Regulatory
MAR
Corporate Information
Other Corporate Information
XVIVO Perfusion launches Perfadex Plus, an upgraded ready to use version of Perfadex
2018-05-14 14:00
News
IR
Swedish
Regulatory
MAR
Corporate Information
Other Corporate Information
Positiva fynd i PrimECC®-studien
2018-05-14 14:00
News
IR
English
Regulatory
MAR
Corporate Information
Other Corporate Information
Positive findings in the PrimECC study
2018-05-11 06:00
News
IR
Swedish
Regulatory
MAR
Corporate Information
Other Corporate Information
PMA ansökan för STEEN Solution™ och XPS™ inlämnad till FDA
2018-05-11 06:00
News
IR
English
Regulatory
MAR
Corporate Information
Other Corporate Information
PMA application for XPS™ with STEEN Solution™ submitted to the FDA
2018-04-27 14:40
News
IR
Swedish
Regulatory
Listing Regulation
Corporate Information
General meeting
Report of the AGM
Kommuniké från årsstämma i XVIVO Perfusion AB (publ)
2018-04-27 14:40
News
IR
English
Regulatory
Listing Regulation
Corporate Information
General meeting
Report of the AGM
Report from Annual general meeting of XVIVO Perfusion AB (publ)
2018-04-26 07:00
News
IR
Swedish
Regulatory
MAR
Report
Interim
Q1
XVIVO Perfusion AB (publ) delårsrapport januari – mars 2018
2018-04-26 07:00
News
IR
English
Regulatory
MAR
Report
Interim
Q1
XVIVO Perfusion AB (publ) Interim Report January – March 2018
2018-04-19 10:00
News
IR
Swedish
Corporate Information
Other Corporate Information
Telefonkonferens avseende delårsrapport
2018-04-19 10:00
News
IR
English
Corporate Information
Other Corporate Information
Conference call on Interim Report
2018-04-04 12:00
News
IR
Swedish
Regulatory
VPML
Report
Annual
Årsredovisning 2017
2018-04-04 12:00
News
IR
English
Regulatory
VPML
Corporate Information
Other Corporate Information
Annual Report 2017
2018-03-22 09:30
News
IR
Swedish
Regulatory
Listing Regulation
Corporate Information
General meeting
Notice
Kallelse till årsstämma i XVIVO Perfusion AB (publ)
2018-03-22 09:30
News
IR
English
Regulatory
Listing Regulation
Corporate Information
General meeting
Notice
Annual General Meeting of XVIVO Perfusion AB (publ)
2018-03-22 08:30
News
IR
Swedish
Corporate Information
Other Corporate Information
Optionsprogram till VD och vice VD/CFO
2018-03-22 08:30
News
IR
English
Corporate Information
Other Corporate Information
Option program for the CEO and the deputy CEO
2018-03-08 15:00
News
IR
Swedish
Regulatory
Listing Regulation
Corporate Information
Other Corporate Information
Information från XVIVO Perfusions Valberedning
2018-03-08 15:00
News
IR
English
Regulatory
Listing Regulation
Corporate Information
Other Corporate Information
Information from XVIVO Perfusion´s Nomination Committee
2018-02-09 08:00
News
IR
Swedish
Regulatory
MAR
VPML
Report
Interim
Yearend
XVIVO Perfusion AB (publ) Bokslutskommuniké 2017
2018-02-09 08:00
News
IR
English
Regulatory
MAR
VPML
Report
Interim
Yearend
XVIVO Perfusion AB (publ) Report on Operations 2017
2018-02-05 09:00
News
IR
Swedish
Corporate Information
Other Corporate Information
Ändrat datum för Telefonkonferens avseende bokslutskommuniké
2018-02-05 09:00
News
IR
English
Corporate Information
Other Corporate Information
Date changed for Conference call on Report on Operations
2018-02-01 15:00
News
IR
English
Corporate Information
Other Corporate Information
Conference call on Report on Operations
2018-02-01 15:00
News
IR
Swedish
Corporate Information
Other Corporate Information
Telefonkonferens avseende bokslutskommuniké
2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012
2018-10-26 07:30
News
IR
Swedish
Regulatory
MAR
Report
Interim
Q3
XVIVO Perfusion AB (publ) delårsrapport januari – september 2018
2018-10-26 07:30
News
IR
English
Regulatory
MAR
Report
Interim
Q3
XVIVO Perfusion AB (publ) Interim Report January – September 2018
2018-07-20 08:00
News
IR
English
Regulatory
MAR
VPML
Report
Interim
Q2
Interim report January-June 2018
2018-07-20 08:00
News
IR
Swedish
Regulatory
MAR
VPML
Report
Interim
Q2
Delårsrapport januari-juni 2018
2018-06-29 08:30
News
IR
English
Regulatory
LHFI
Corporate Action
Shares
Change in number of shares and votes in XVIVO Perfusion
2018-06-29 08:30
News
IR
Swedish
Regulatory
LHFI
Corporate Action
Shares
Förändring av antalet aktier och röster i XVIVO Perfusion
2018-06-14 20:00
News
IR
English
Regulatory
Listing Regulation
Corporate Information
Other Corporate Information
XVIVO Perfusion changes the date of reporting of the interim report January - June 2018 to July 20, 2018
2018-06-14 20:00
News
IR
Swedish
Regulatory
Listing Regulation
Corporate Information
Other Corporate Information
XVIVO Perfusion ändrar datum för rapportering av delårsrapport januari – juni 2018 till den 20 juli 2018
2018-06-12 07:30
News
IR
Swedish
Regulatory
MAR
Corporate Information
Other Corporate Information
UNITED THERAPEUTICS OCH XVIVO PERFUSION INLEDER SAMARBETE FÖR ATT MINSKA ORGANBRISTEN GENOM UTÖKAD TJÄNST INOM ORGANUTVÄRDERING
2018-06-12 07:30
News
IR
English
Regulatory
MAR
Corporate Information
Other Corporate Information
UNITED THERAPEUTICS AND XVIVO PERFUSION ANNOUNCE COLLABORATION TO REDUCE ORGAN SHORTAGE THROUGH EXPANSION OF ORGAN EVALUATION SERVICE
2018-06-05 08:30
News
IR
Swedish
Regulatory
MAR
Corporate Information
Other Corporate Information
Xvivo Perfusion lanserar Perfadex Plus, en uppgraderad ready to use version av Perfadex
2018-06-05 08:30
News
IR
English
Regulatory
MAR
Corporate Information
Other Corporate Information
XVIVO Perfusion launches Perfadex Plus, an upgraded ready to use version of Perfadex
2018-05-14 14:00
News
IR
Swedish
Regulatory
MAR
Corporate Information
Other Corporate Information
Positiva fynd i PrimECC®-studien
2018-05-14 14:00
News
IR
English
Regulatory
MAR
Corporate Information
Other Corporate Information
Positive findings in the PrimECC study
2018-05-11 06:00
News
IR
Swedish
Regulatory
MAR
Corporate Information
Other Corporate Information
PMA ansökan för STEEN Solution™ och XPS™ inlämnad till FDA
2018-05-11 06:00
News
IR
English
Regulatory
MAR
Corporate Information
Other Corporate Information
PMA application for XPS™ with STEEN Solution™ submitted to the FDA
2018-04-27 14:40
News
IR
Swedish
Regulatory
Listing Regulation
Corporate Information
General meeting
Report of the AGM
Kommuniké från årsstämma i XVIVO Perfusion AB (publ)
2018-04-27 14:40
News
IR
English
Regulatory
Listing Regulation
Corporate Information
General meeting
Report of the AGM
Report from Annual general meeting of XVIVO Perfusion AB (publ)
2018-04-26 07:00
News
IR
Swedish
Regulatory
MAR
Report
Interim
Q1
XVIVO Perfusion AB (publ) delårsrapport januari – mars 2018
2018-04-26 07:00
News
IR
English
Regulatory
MAR
Report
Interim
Q1
XVIVO Perfusion AB (publ) Interim Report January – March 2018
Next
About us

Founded in 1998, XVIVO is the only medical technology company dedicated to extending the life of all major organs so transplant teams around the world can save more lives.
Our solutions allow leading clinicians and researchers to push the boundaries of transplantation medicine.
XVIVO is headquartered in Gothenburg, Sweden, and has offices and research sites on three continents. The company is listed on Nasdaq.

Contact

Swedish Office
XVIVO Perfusion AB
Box 53015
SE-400 14 Göteborg
Sweden

Phone: +46 31 788 21 50
Fax: +46 31 788 21 69
info@xvivogroup.com

 

Report a violations or breach here: Whistleblower

  • Home
  • Technology
  • Products
  • Knowledge
  • Media
  • About us
  • Corporate

Copyright © 2023 XVIVO. All rights reserved.

Design mkmedia
To top

We use cookies to improve the user experience on XVIVO. Read more about Cookies

Approve